|
Market Closed -
London S.E.
11:35:09 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 188.50 GBX | -1.57% |
|
+1.34% | +47.27% |
| 09-24 | Diaceutics PLC And Syndax Pharmaceuticals, Inc. Expand Multi-Year Relay Partnership | CI |
| 09-22 | EARNINGS: Origin Enterprises beats operating profit target | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.95x | - | 3.31x | 15.2x | 48.38x | -.--% | 215M | |
| -99.1x | 6.14x | 0.26x | 23.15x | 55.62x | -80.56x | -.--% | 63.56B | |
| -681.83x | - | 6.94x | - | - | - | - | 3.68B | |
| 34.42x | 3.37x | 0.63x | 2.54x | 19.86x | 36.81x | 1.33% | 3.42B | |
| 105.14x | 5.74x | 2.7x | 11.64x | 18.48x | 99.48x | 0.35% | 2.97B | |
| -8.94x | - | -0.01x | 6.04x | 14.71x | 62.82x | - | 2.69B | |
| 31.17x | 11.32x | 1.95x | 9.79x | 21.1x | 24.54x | 2.2% | 1.79B | |
| 31.56x | 2.61x | 3.22x | 4.24x | 16.84x | 21.91x | 0.56% | 1.49B | |
| -78.74x | 3.94x | 0.92x | - | - | - | 0.09% | 1.35B | |
| 39.4x | 8x | 1.22x | 16.28x | 25.26x | 28.61x | 0.59% | 1.17B | |
| 11.29x | 2.82x | 0.63x | - | - | - | 0.45% | 948M | |
| -1.49x | - | 0.12x | - | - | - | -.--% | 381M | |
| 206.73x | 6.25x | -1.71x | 1.9x | 11.04x | 68.97x | - | 169M | |
| 29.01x | 3.01x | -5.46x | 2.58x | 8.79x | 15.63x | - | 151M | |
| Average | -29.34x | 5.19x | 0.88x | 8.15x | 20.69x | 32.66x | 0.56% | 6B | |
| Weighted average by Cap. | -99.22x | 5.99x | 0.75x | 20.30x | 48.91x | -56.63x | 0.15% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
